Erin Burkhart
Vermögen: 811 971 $ am 31.05.2026
Vermögen: 811 971 $ am 31.05.2026
Erin E.
Burkhart is Chief Accounting Officer, Senior VP & Controller at Gilead Sciences, Inc. starting in 2025.
Former roles include Chief Accounting Officer & Group Vice President at BioMarin Pharmaceutical, Inc. from 2022 to 2025, and Associate VP-US Gross-to-Net Business Analysis at Eli Lilly & Co. from 2021 to 2022.
Education includes undergraduate studies at Butler University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2025 | 14 173 ( 0,01 % ) | 811 971 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GILEAD SCIENCES, INC. | Comptroller/Controller/Auditor | 22.09.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Comptroller/Controller/Auditor | 02.09.2025 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.04.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Butler University
Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen